Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
Spectrum Pharma Spikes on Positive Lung Cancer Treatment Data
By Tony Owusu
Jul 28, 2020 8:44 AM EDT
PRESS RELEASES
Spectrum Pharmaceuticals Announces Two Oral Presentations At Upcoming IASLC 2020 World Conference On Lung Cancer
By Business Wire
Jan 22, 2021 7:00 AM EST
PRESS RELEASES
Spectrum Pharmaceuticals To Participate In Three Upcoming Investor Conferences In January
By Business Wire
Jan 5, 2021 7:00 AM EST
PRESS RELEASES
Spectrum Provides Poziotinib Update After Successful Pre-NDA Meeting With The FDA
By Business Wire
Dec 22, 2020 4:05 PM EST
PRESS RELEASES
BeyondSpring Announces The Appointment Of Dr. Jeffrey Vacirca To Its Board Of Directors
By GlobeNewswire
Dec 17, 2020 8:00 AM EST
PRESS RELEASES
Spectrum Pharmaceuticals Appoints Nora Brennan To Board Of Directors
By Business Wire
Dec 14, 2020 7:00 AM EST
PRESS RELEASES
Spectrum Pharmaceuticals Announces Three Poster Presentations At Upcoming San Antonio Breast Cancer Symposium
By Business Wire
Dec 4, 2020 7:00 AM EST
PRESS RELEASES
Spectrum Pharmaceuticals To Present At Two Upcoming Investor Conferences In November
By Business Wire
Nov 9, 2020 7:00 AM EST
PRESS RELEASES
Spectrum Pharmaceuticals Presents Results In HER2 Exon 20 Insertion Mutations From Cohort 2 Of The Poziotinib ZENITH20 Clinical Trial
By Business Wire
Sep 18, 2020 7:00 AM EDT
PRESS RELEASES
Spectrum Pharmaceuticals Announces Two Presentations For Poziotinib At ESMO Virtual Congress 2020
By Business Wire
Sep 14, 2020 7:00 AM EDT
PRESS RELEASES
Spectrum Pharmaceuticals Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares
By Business Wire
Aug 5, 2020 4:00 PM EDT
PRESS RELEASES
Spectrum Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
By Business Wire
Jul 30, 2020 7:00 AM EDT
PRESS RELEASES
Spectrum Pharmaceuticals Announces Proposed Public Offering Of Common Stock
By Business Wire
Jul 29, 2020 4:27 PM EDT
INVESTING
Spectrum Pharma Spikes on Positive Lung Cancer Treatment Data
By Tony Owusu
Jul 28, 2020 8:44 AM EDT
PRESS RELEASES
Spectrum Pharmaceuticals Announces Positive Topline Results In HER2 Exon20 Insertion Mutations From Cohort 2 Of The Poziotinib ZENITH20 Trial
By Business Wire
Jul 27, 2020 4:00 PM EDT
PRESS RELEASES
Tarsus Pharmaceuticals Announces Appointment Of New COO And CFO
By PR Newswire
Jul 16, 2020 9:00 AM EDT
PRESS RELEASES
Spectrum Pharmaceuticals Presents Same Day Dosing Data For ROLONTIS® (eflapegrastim) At AACR Virtual Annual Meeting II
By Business Wire
Jun 22, 2020 9:00 AM EDT
PRESS RELEASES
Spectrum Pharmaceuticals To Present Preclinical ROLONTIS® (eflapegrastim) Same Day Dosing Data At AACR Virtual Annual Meeting II
By Business Wire
Jun 16, 2020 7:00 AM EDT
PRESS RELEASES
Spectrum Pharmaceuticals Appoints Lyndah K. Dreiling, M.D., MBA, As Senior Vice President, Clinical Development
By Business Wire
Jun 3, 2020 4:00 PM EDT
PRESS RELEASES
Spectrum Pharmaceuticals To Present At The Jefferies Virtual Healthcare Conference 2020
By Business Wire
May 27, 2020 7:00 AM EDT
PRESS RELEASES
Spectrum Pharmaceuticals Initiates Same Day Dosing Clinical Trial For ROLONTIS® (eflapegrastim)
By Business Wire
Apr 30, 2020 7:00 AM EDT
PRESS RELEASES
Spectrum Pharmaceuticals Appoints Seth H.Z. Fischer To Board Of Directors
By Business Wire
Apr 23, 2020 7:00 AM EDT
PRESS RELEASES
Spectrum Pharmaceuticals To Present Data From Phase 2 Clinical Trial For Poziotinib At American Association For Cancer Research Virtual Annual Meeting 2020
By Business Wire
Apr 21, 2020 7:00 AM EDT
PRESS RELEASES
Spectrum Pharmaceuticals Cancelled Participation In Upcoming Medical Conference Due To Coronavirus Pandemic
By Business Wire
Mar 17, 2020 7:00 AM EDT
PRESS RELEASES
Spectrum Pharmaceuticals To Present Data From Phase 2 Clinical Trial For Poziotinib At Upcoming Medical Conference
By Business Wire
Mar 11, 2020 7:00 AM EDT
